D. Tidd

发表

A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.

D. Tidd, A. Paterson, 1974, Cancer research.

Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O.

D. Spiller, D. Tidd, David G. Spiller, 1995, Antisense research and development.

Specific and sensitive combined high-performance liquid chromatographic-flow fluorometric assay for intracellular 6-thioguanine nucleotides metabolites of 6-mercaptopurine and 6-thioguanine.

S. Dedhar, D. Tidd, 1978, Journal of chromatography.

Abrogation of c-MYC protein degradation in human lymphocyte lysates by prior precipitation with perchloric acid.

D. Spiller, D. Tidd, 1992, Journal of immunological methods.

Partial circumvention of resistance to 6-mercaptopurine by acylated P1,P2-bis(6-mercaptopurine-9-beta-D-ribofuranoside-5') pyrophosphate derivatives.

I. Gibson, D. Tidd, P. Dean, 1982, Cancer research.

Expression of c-myc is not critical for cell proliferation in established human leukemia lines

R. Clark, R. V. Giles, D. Tidd, 2001, BMC Molecular Biology.

Antisense Oligonucleotides as Potential Inhibitors of Gene Expression

D. Tidd, 1993 .

The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus.

D. Tidd, S. Dryden, L. Pickavance, 1998, The Journal of endocrinology.

The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.

I. Gibson, D. Tidd, P. Hawley, 1985, British Journal of Cancer.

Effects of bis(6-mercaptopurine-9-beta-D-ribofuranoside)-5',5"-phosphate and its butyryl derivative on mouse leukaemia L1210 and a 6-mercaptopurine-resistant subline in culture.

I. Gibson, D. Tidd, H. P. Johnston, 1982, Biochemical pharmacology.

Specificity of antisense oligonucleotides

D. Tidd, 1996 .

Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine.

D. Tidd, A. Paterson, 1974, Cancer research.

The uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells.

D. Spiller, D. Tidd, 1992, Anti-cancer drug design.

Synthesis and properties of poly(9-vinylpurine-6-thiol), a polyvinyl thiopurine analog of polyriboinosinic acid

D. Tidd, P. Dean, H. Potuzak, 1979 .

A delayed cytotoxic reaction for 6-mercaptopurine.

D. Tidd, A. Paterson, K. Horáková, 1972, Cancer research.

A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.

D. Tidd, 1990, Anticancer research.

Oligodeoxynucleotide 5mers containing a 5'-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cells.

D. Spiller, R. Clark, R. V. Giles, 2000, Nucleic acids research.

CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesis.

R. Clark, D. Tidd, C. Broughton, 2003, Nucleic acids research.

The free surface flow of Newtonian and non-Newtonian fluids trapped by surface tension

D. M. Tidd, R. W. Thatcher, A. Kaye, 1988 .

Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells.

D. Spiller, S. Edwards, M. White, 2000, Blood.

Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells.

D. Spiller, R. V. Giles, D. Tidd, 1995, Nucleic acids research.